PARFENOV, E.V.,
MUKAEVA, V.R.,
FARRAKHOV, R.G.,
PARFENOVA, L.V.,
LUKINA, E.S.,
DYAKONOV, G.S.,
VALIEV, R.Z.,
DANILKO, K.V. (2019) presencein the PEO coating pores was proven by the EIS. For the in vitro tests,
fibroblasts were used
PARFENOVA, L.V.,
LUKINA, E.S.,
GALIMSHINA, Z.R.,
GIL'FANOVA, G.U.,
MUKAEVA, V.R.,
FARRAKHOV, R.G.,
PARFENOV, E.V.,
DANILKO, K.V.,
DYAKONOV, G.S. (2020) on proliferation and viability of
fibroblasts, mesenchymal stem cells and osteoblastlike cells showed
Zhao, X.,
Sun, J.,
Su, W.,
Shan, H.,
Zhang, B.,
Wang, Y.,
Shabanova, A.,
Shan, H.,
Liang, H. (2018) fibroblasts. Additionally, we determined that luzindole, a melatonin receptor inhibitor, reduced the anti
-cardiomyocytes such as cardiac
fibroblasts, were shown to be reprogrammed into cardiomyocytes and thus favor the repair
Bikkuzin, T.,
Shi, Y.,
Sun, B.,
Guo, Y.,
Jin, X.,
Han, Z.,
V.N. Pavlov,
Zhang, H. (2019) cultured human corneal
fibroblasts. Reprogramming was performed using episomal vector delivery of OCT4, SOX